Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Operating Expenses (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Operating Expenses for 16 consecutive years, with $1.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Expenses rose 14.72% to $1.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.1 million, a 7.98% increase, with the full-year FY2024 number at $5.8 million, up 2.22% from a year prior.
  • Operating Expenses was $1.3 million for Q3 2025 at Creative Medical Technology Holdings, up from $1.3 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $6.3 million in Q4 2022 to a low of $303944.0 in Q1 2021.
  • A 5-year average of $1.5 million and a median of $1.3 million in 2025 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: surged 351.35% in 2021, then tumbled 71.81% in 2023.
  • Creative Medical Technology Holdings' Operating Expenses stood at $1.5 million in 2021, then surged by 319.1% to $6.3 million in 2022, then crashed by 71.81% to $1.8 million in 2023, then increased by 6.42% to $1.9 million in 2024, then crashed by 32.56% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Operating Expenses are $1.3 million (Q3 2025), $1.3 million (Q2 2025), and $1.7 million (Q1 2025).